FFTY:NYE-Innovator IBD 50 ETF (USD)

ETF | Mid-Cap Growth | NYE

Last Closing Price

USD 44.03

Change

0.00 (0.00)%

Market Cap

USD 0.25B

Volume

0.03M

Average Target Price

N/A
Average Analyst Rating

N/A

Fundamental Analysis

Verdict

About

The investment seeks to track, before fees and expenses, the performance of the IBD® 50 Index (the index). The fund will normally invest at least 80% of its net assets (including investment borrowings) in securities that comprise the index. The IBD® 50 Index is a weekly, rules-based, computer-generated stock index compiled and published by Investor's Business Daily® (IBD or the index provider) that seeks to identify the current top 50 growth stocks.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Sectors

N/A

Top Regions

N/A

Valuation Growth & Performance

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-06-20 )

Largest Industry Peers for Mid-Cap Growth

Symbol Name Mer Price(Change) Market Cap
VOT Vanguard Mid-Cap Growth Index .. 0.07 %

N/A

USD22.11B
IWP iShares Russell Mid-Cap Growth.. 0.24 %

N/A

USD14.82B
IJK iShares S&P Mid-Cap 400 Growth.. 0.17 %

N/A

USD8.24B
MDYG SPDR S&P 400 Mid Cap Growth ET.. 0.15 %

N/A

USD1.63B
JKH iShares Morningstar Mid-Cap Gr.. 0.06 %

N/A

USD1.59B
IVOG Vanguard S&P Mid-Cap 400 Growt.. 0.15 %

N/A

USD1.09B
XMMO Invesco S&P MidCap Momentum ET.. 0.34 %

N/A

USD0.94B
IPO Renaissance IPO ETF 0.60 %

N/A

USD0.65B
PXMG Invesco S&P MidCap Momentum ET.. 0.39 %

N/A

USD0.61B
RFG Invesco S&P MidCap 400 Pure Gr.. 0.35 %

N/A

USD0.40B

ETFs Containing FFTY

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Mid-Cap Growth)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.26% 47% F 46% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.26% 47% F 44% F
Trailing 12 Months  
Capital Gain 28.93% 18% F 48% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 28.93% 18% F 43% F
Trailing 5 Years  
Capital Gain 106.91% 67% D+ 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 106.91% 67% D+ 78% C+
Average Annual (5 Year Horizon)  
Capital Gain 15.91% 59% F 78% C+
Dividend Return 0.05% 18% F 2% F
Total Return 15.96% 59% F 76% C
Risk Return Profile  
Volatility (Standard Deviation) 20.98% 53% F 53% F
Risk Adjusted Return 76.06% 65% D 83% B
Market Capitalization 0.25B 47% F 28% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.